These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26700862)

  • 1. Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner.
    Chen C; Lu M; Pan Q; Fichna J; Zheng L; Wang K; Yu Z; Li Y; Li K; Song A; Liu Z; Song Z; Kreis M
    PLoS One; 2015; 10(12):e0145556. PubMed ID: 26700862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Zielińska M; Jarmuż A; Wasilewski A; Cami-Kobeci G; Husbands S; Fichna J
    Pharmacol Rep; 2017 Apr; 69(2):350-357. PubMed ID: 28187396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
    Zielińska M; Jarmuż A; Sałaga M; Lipkowski AW; Fichna J
    Pharmacol Rep; 2016 Feb; 68(1):32-6. PubMed ID: 26721348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
    Zielińska M; Chen C; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Małecka-Panas E; Wlaź P; Krajewska WM; Fichna J
    J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
    Sobczak M; Cami-Kobeci G; Sałaga M; Husbands SM; Fichna J
    Eur J Pharmacol; 2014 Aug; 736():63-9. PubMed ID: 24815321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS.
    Fichna J; Sobczak M; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Cenac N; Sałaga M; Timmermans JP; Vergnolle N; Małecka-Panas E; Krajewska WM; Storr M
    Neurogastroenterol Motil; 2014 Nov; 26(11):1539-50. PubMed ID: 25041572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
    Sałaga M; Polepally PR; Sobczak M; Grzywacz D; Kamysz W; Sibaev A; Storr M; Do Rego JC; Zjawiony JK; Fichna J
    J Pharmacol Exp Ther; 2014 Jul; 350(1):69-78. PubMed ID: 24891526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
    Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
    Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
    World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.
    Scarpellini E; Laterza L; Ianiro G; Tack J; Abenavoli L; Gasbarrini A
    Expert Opin Pharmacother; 2016 Jul; 17(10):1395-402. PubMed ID: 27267380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
    Paragomi P; Rahimian R; Kazemi MH; Gharedaghi MH; Khalifeh-Soltani A; Azary S; Javidan AN; Moradi K; Sakuma S; Dehpour AR
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):118-26. PubMed ID: 24471407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
    Zhang JD; Liu J; Zhu SW; Fang Y; Wang B; Jia Q; Hao HF; Kao JY; He QH; Song LJ; Liu F; Zhu BL; Owyang C; Duan LP
    Acta Pharmacol Sin; 2021 Nov; 42(11):1821-1833. PubMed ID: 33558654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
    Lacy BE
    Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational evaluation of Gelsectan
    Inczefi O; Eutamene H; Placide F; Tondereau V; Pallagi P; Bagyánszki M; Bódi N; Gémes N; Szebeni G; Molnár T; Theodorou V; Róka R
    United European Gastroenterol J; 2024 Oct; 12(8):1102-1113. PubMed ID: 39106086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome.
    Zhou TR; Huang JJ; Huang ZT; Cao HY; Tan B
    World J Gastroenterol; 2018 Feb; 24(6):693-705. PubMed ID: 29456408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
    Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome.
    Sałaga M; Kowalczuk A; Zielinska M; Błażewicz A; Fichna J
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1069-77. PubMed ID: 26068703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.